News
-
-
-
-
PRESS RELEASE
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access -
-
-
-
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital as of March 31, 2024. This announcement complies with relevant regulatory requirements